HydroxycarbamideAcute myeloid leukaemia and leukaemia following off label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72687-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：250 / 250

相关论文

共 50 条

[1] HydroxycarbamideAcute lymphoblastic leukaemia and acute myeloid leukaemia: 2 case reports
Reactions Weekly, 2018, 1697 (1) : 185 - 185
[2] Anakinra/hydroxycarbamideAcute myeloid leukaemia and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 49 - 49
[3] HydroxycarbamideAcute myeloid leukaemia: case report
Reactions Weekly, 2012, 1389 (1) : 26 - 26
[4] LenalidomideFatal acute myeloid leukaemia following off-label treatment: 2 case reports
Reactions Weekly, 2019, 1781 (1) : 214 - 214
[5] HydroxycarbamideAcute myeloid leukaemia : case report
Reactions Weekly, 2021, 1860 (1) : 191 - 191
[6] HydroxycarbamideAcute myeloid leukaemia: case report
Reactions Weekly, 2004, 989 (1) : 11 - 11
[7] Daratumumab/dexamethasoneAcute myeloid leukaemia and off-label use: case report
Reactions Weekly, 2020, 1787 (1) : 170 - 170
[8] AntineoplasticsAcute myeloid leukaemia, lack of efficacy and off label use: case report
Reactions Weekly, 2023, 1982 (1) : 41 - 41
[9] Multiple drugsAcute myeloid leukaemia, off label use and compassionate use
Reactions Weekly, 2024, 1990 (1) : 119 - 119
[10] AntineoplasticsAcute myelomonocytic leukaemia and acute myeloid leukaemia: 2 case reports
Reactions Weekly, 2016, 1583 (1) : 99 - 99

← 1 2 3 4 5 →